BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10726633)

  • 1. Pure dysgerminoma of the ovary: a review of 45 well staged cases.
    Ayhan A; Bildirici I; Günalp S; Yuce K
    Eur J Gynaecol Oncol; 2000; 21(1):98-101. PubMed ID: 10726633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysgerminoma: the role of conservative surgery.
    Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
    Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pure dysgerminoma of the ovary. 12 case reports].
    Kdous M; Hachicha R; Gamoudi A; Boussen H; Benna F; Rahal K
    Tunis Med; 2003 Dec; 81(12):937-43. PubMed ID: 14986529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
    Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
    Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
    Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure dysgerminoma of the ovary: a single institutional experience of 65 patients.
    A L Husaini H; Soudy H; El Din Darwish A; Ahmed M; Eltigani A; A L Mubarak M; Sabaa AA; Edesa W; A L-Tweigeri T; Al-Badawi IA
    Med Oncol; 2012 Dec; 29(4):2944-8. PubMed ID: 22407668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
    Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Scollo P; Viganò R; Gamucci T; Candiani M; Pignata S
    Gynecol Oncol; 2011 May; 121(2):280-4. PubMed ID: 21277010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
    Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
    Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
    Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
    J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian dysgerminoma in children and adolescents. Retrospective clinico-pathologic study].
    Zuntová A; Sumerauer D; Teslík L; Koutecký J
    Cas Lek Cesk; 2004; 143(4):246-52. PubMed ID: 15218724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful pregnancy after conservative surgery and chemotherapy for dysgerminoma of the ovary: case report].
    Studziński Z; Kaliński S; Filipczak A; Branicka D
    Ginekol Pol; 1999 Aug; 70(8):553-7. PubMed ID: 10534934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
    Zhang R; Hong W; Li S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of optimal cytoreduction in patients with dysgerminoma.
    Bandala-Jacques A; Estrada-Rivera F; Cantu D; Prada D; Montalvo-Esquivel G; González-Enciso A; Barquet-Munoz SA
    Int J Gynecol Cancer; 2019 Nov; 29(9):1405-1410. PubMed ID: 31594835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Dysgerminoma: A Tertiary Center Experience.
    Kilic C; Cakir C; Yuksel D; Kilic F; Kayikcioglu F; Koc S; Korkmaz V; Kimyon Comert G; Turkmen O; Boran N; Turan T
    J Adolesc Young Adult Oncol; 2021 Jun; 10(3):303-308. PubMed ID: 32762565
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysgerminoma of the ovary: review of 27 cases.
    Susnerwala SS; Pande SC; Shrivastava SK; Dinshaw KA
    J Surg Oncol; 1991 Jan; 46(1):43-7. PubMed ID: 1986147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
    Gordon A; Lipton D; Woodruff JD
    Obstet Gynecol; 1981 Oct; 58(4):497-504. PubMed ID: 7279343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.